Cite
HARVARD Citation
Pantuck, A. et al. (2018). Artificial Intelligence: Modulating BET Bromodomain Inhibitor ZEN‐3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE.AI, an Artificial Intelligence Platform (Adv. Therap. 6/2018). Advanced therapeutics. 1 (6), p. n/a. [Online].